Manidipine: a review of its use in the management of hypertension.

[1]  A. Semplicini,et al.  Effect of Manidipine on Gene Expression and Protein Level of Oxidative Stress-Related Proteins: p22phox and HO-1: Relevance for Antihypertensive and Anti-Remodeling Effects , 2004, Journal of cardiovascular pharmacology.

[2]  F. Locatelli,et al.  Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril. , 2004, Journal of nephrology.

[3]  M. Hosono,et al.  Orally administered benidipine and manidipine prevent ischemia-reperfusion injury in the rat heart. , 2004 .

[4]  E. Johns.  Smoking is bad for you: our genes say so! , 2004, Journal of hypertension.

[5]  S. Mochizuki,et al.  Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study. , 2003, Current therapeutic research, clinical and experimental.

[6]  J. Kostis.  Treatment of hypertension in older patients: an updated look at the role of calcium antagonists. , 2003, The American journal of geriatric cardiology.

[7]  T. Saruta,et al.  Role of Actions of Calcium Antagonists on Efferent Arterioles – with Special References to Glomerular Hypertension , 2003, American Journal of Nephrology.

[8]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[9]  K. Harada,et al.  Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[10]  G. Mazzaglia,et al.  Effects of Manidipine and Nifedipine on Blood Pressure and Renal Function in Patients with Chronic Renal Failure: A Multicenter Randomized Controlled Trial , 2003, Renal failure.

[11]  F. Veglio,et al.  Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study , 2002, Journal of hypertension.

[12]  C. Ram.  Usefulness of lercanidipine, a new calcium antagonist, for systemic hypertension. , 2002, The American journal of cardiology.

[13]  Artur Beltrame Ribeiro,et al.  Manidipina no tratamento da hipertensão arterial essencial estágio I e II do paciente com sobrepeso ou obesidade andróide. Estudo multicêntrico brasileiro de eficácia, tolerabilidade e efeitos metabólicos , 2001 .

[14]  A. Zanchetti,et al.  Efficacy, Tolerability, and Impact on Quality of Life of Long-Term Treatment with Manidipine or Amlodipine in Patients with Essential Hypertension , 2001, Journal of cardiovascular pharmacology.

[15]  R. Fogari,et al.  Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension , 2000, Journal of hypertension.

[16]  Thomas Hedner,et al.  Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.

[17]  G Mancia,et al.  Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients. , 2000, Journal of cardiovascular pharmacology.

[18]  T. Ogihara.  Practitioner's Trial on the Efficacy of Antihypertensive Treatment in the Elderly Hypertension (The PATE-Hypertension Study) in Japan. , 2000, American journal of hypertension.

[19]  H. Yamazaki,et al.  Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug–drug interactions , 2000, European Journal of Clinical Pharmacology.

[20]  Y. Iwamoto,et al.  Delapril versus manidipine in hypertensive therapy to halt the type-2-diabetes-mellitus-associated nephropathy. , 2000, Diabetes research and clinical practice.

[21]  R. Fogari,et al.  Effect of Low-Dose Manidipine on Ambulatory Blood Pressure in Very Elderly Hypertensives , 1999, Cardiovascular Drugs and Therapy.

[22]  M. Nagase,et al.  LONG‐TERM EFFECT OF MANIDIPINE ON RENAL FUNCTION AND STRUCTURE IN UNINEPHRECTOMIZED SPONTANEOUSLY HYPERTENSIVE RATS , 1997, Clinical and experimental pharmacology & physiology.

[23]  M. Hayakawa,et al.  Effect of Dihydropyridine Calcium Channel Blockers on the Plasma Digoxin Level , 1996 .

[24]  Y. Hinokio,et al.  Effect of manidipine and delapril on insulin sensitivity in type 2 diabetic patients with essential hypertension. , 1996, Diabetes research and clinical practice.

[25]  Y. Miyazaki,et al.  Effects of a calcium channel blocker, manidipine, on insulin sensitivity in essential hypertensives. , 1995, Journal of diabetes and its complications.

[26]  A. Hishida,et al.  Effects of a calcium antagonist, manidipine, on progressive renal injury associated with mild hypertension in remnant kidneys. , 1995, The Journal of laboratory and clinical medicine.

[27]  J. Tsai,et al.  Effects of manidipine hydrochloride on blood pressure in hypertensive patients--a comparison with nifedipine retard. , 1993, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.

[28]  T. Saruta,et al.  Efficacy of manidipine in the treatment of hypertension with renal impairment: a multicenter trial. , 1993, American heart journal.

[29]  A. Luger,et al.  An evaluation of the renal protective effect of manidipine in the uninephrectomized spontaneously hypertensive rat. , 1993, American heart journal.

[30]  Å. Wennmalm.  Nitric oxide (NO) in the cardiovascular system. Some physiological and evolutionary aspects. , 1992, Blood pressure.

[31]  T. Kitayoshi,et al.  Calcium channel blocking action of franidipine hydrochloride (CV-4093.2HCl) in vitro and in vivo. , 1988, Japanese journal of pharmacology.

[32]  Y. Hattori,et al.  Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists. , 1988, European journal of pharmacology.

[33]  T. Sasaki,et al.  Renal effects of manidipine hydrochloride , 2004, European Journal of Clinical Pharmacology.